Latest Insider Transactions at Atri Cure, Inc. (ATRC)
This section provides a real-time view of insider transactions for Atri Cure, Inc. (ATRC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AtriCure, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AtriCure, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 17
2020
|
Salvatore Privitera Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
10,654
-13.5%
|
$543,354
$51.33 P/Share
|
Dec 17
2020
|
Michael H Carrel President, CEO, & Director |
SELL
Open market or private sale
|
Direct |
75,000
-4.72%
|
$3,825,000
$51.0 P/Share
|
Dec 17
2020
|
Michael H Carrel President, CEO, & Director |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+4.51%
|
$750,000
$10.95 P/Share
|
Dec 09
2020
|
Salvatore Privitera Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
3,846
-4.65%
|
$180,762
$47.5 P/Share
|
Nov 17
2020
|
Scott William Drake Director |
BUY
Open market or private purchase
|
Direct |
12,350
+23.13%
|
$494,000
$40.54 P/Share
|
Nov 10
2020
|
Justin J Noznesky Chief Mktg & Strategy Officer |
SELL
Bona fide gift
|
Direct |
250
-0.49%
|
-
|
Oct 09
2020
|
Douglas J Seith Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
29,161
-18.38%
|
$1,166,440
$40.09 P/Share
|
Oct 06
2020
|
Mark A Collar Director |
SELL
Open market or private sale
|
Direct |
2,330
-2.88%
|
$93,200
$40.0 P/Share
|
Oct 01
2020
|
Mark A Collar Director |
SELL
Open market or private sale
|
Direct |
670
-0.82%
|
$26,800
$40.2 P/Share
|
Mar 06
2019
|
Douglas J Seith Chief Operating Officer |
SELL
Open market or private sale
|
Indirect |
3,500
-100.0%
|
$101,500
$29.25 P/Share
|
Mar 06
2019
|
Douglas J Seith Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
7,500
-7.82%
|
$217,500
$29.25 P/Share
|